Sunrise Pharmaceutical Inc
🇺🇸United States
Clinical Trials
3
Active:0
Completed:3
Trial Phases
1 Phases
Not Applicable:3
Drug Approvals
8
FDA:8
Drug Approvals
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE
- Approval Date
- Nov 16, 2023
FDA
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (100.0%)The Sunrise SpO2 and Pulse Rate Accuracy Validation Study
Not Applicable
Completed
- Conditions
- Validation Study
- First Posted Date
- 2022-05-23
- Last Posted Date
- 2022-06-28
- Lead Sponsor
- Sunrise
- Target Recruit Count
- 12
- Registration Number
- NCT05386836
- Locations
- 🇧🇪
Respisom, Namur, Belgium
Validation of an Integrated Digital Solution (SUNrise®) Versus Polysomnography for Obstructive Sleep Apnea Diagnosis
Not Applicable
Completed
- Conditions
- Obstructive Sleep Apnea
- First Posted Date
- 2021-09-27
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Sunrise
- Target Recruit Count
- 848
- Registration Number
- NCT05057975
- Locations
- 🇫🇷
CHU Angers, Angers, France
🇫🇷Hôpitaux Universitaires de Paris Seine Saint-Denis (HUPSSD, AP-HP),, Bobigny,, France
🇫🇷Nouvelle clinique Bel-Air, Bordeaux, France
Transcutaneous Electrical Stimulation in Obstructive Sleep Apnea
Not Applicable
Completed
- Conditions
- Obstructive Sleep Apnea
- First Posted Date
- 2021-06-21
- Last Posted Date
- 2023-04-14
- Lead Sponsor
- Sunrise
- Target Recruit Count
- 42
- Registration Number
- NCT04932486
- Locations
- 🇧🇪
Respisom, Namur, Belgium
News
No news found